Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Venous Thromboembolism”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableStudy completedNCT03977870
What this trial is testing

Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis

Who this might be right for
Venous Thromboembolism (VTE)
Assistance Publique Hopitaux De Marseille 843
Not applicableUnknownNCT04042155
What this trial is testing

Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)

Who this might be right for
Atrial FibrillationRecurrent Venous Thromboembolism
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,600
Post-approval studies (Phase 4)Study completedNCT01989845
What this trial is testing

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Who this might be right for
RivaroxabanCancer-associated ThrombosisRecurrence+1 more
Seoul National University Hospital 127
Not applicableLooking for participantsNCT07083609
What this trial is testing

Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam

Who this might be right for
Cerebral Venous Thrombosis
Hieu Trung Dinh 69
Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Not applicableStudy completedNCT00720915
What this trial is testing

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
McMaster University 410
Large-scale testing (Phase 3)Ended earlyNCT00182247
What this trial is testing

D-Dimer and IPG for Recurrent Thrombosis (DIRECT)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Hamilton Health Sciences Corporation 600
Not applicableWithdrawnNCT05536791
What this trial is testing

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim
Large-scale testing (Phase 3)Study completedNCT03285438
What this trial is testing

REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.

Who this might be right for
Venous Thromboembolism
University Hospital, Brest 2,774
Large-scale testing (Phase 3)Looking for participantsNCT04257487
What this trial is testing

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

Who this might be right for
Venous ThromboembolismAnticoagulantElderly
Arianna Anticoagulazione Foundation 1,455
Large-scale testing (Phase 3)UnknownNCT00222677
What this trial is testing

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism+1 more
University Of Perugia 70
Large-scale testing (Phase 3)Study completedNCT00558259
What this trial is testing

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,353
Not applicableStudy completedNCT01972243
What this trial is testing

Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model

Who this might be right for
Venous Thromboembolism
Medical University of Vienna 800
Not applicableUnknownNCT01382550
What this trial is testing

Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.

Who this might be right for
Venous Thrombosis
Federico II University 900
Large-scale testing (Phase 3)Study completedNCT00000614
What this trial is testing

Prevention of Recurrent Venous Thromboembolism (PREVENT)

Who this might be right for
Cardiovascular DiseasesHeart DiseasesPeripheral Vascular Diseases+3 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableLooking for participantsNCT07016542
What this trial is testing

Cohort for Monitoring Patients With Venous Thromboembolic Disease

Who this might be right for
Venous Thromboembolic Disease
University Hospital, Rouen 2,000
Post-approval studies (Phase 4)Study completedNCT00967304
What this trial is testing

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Who this might be right for
Idiopathic Venous Thromboembolism
Ottawa Hospital Research Institute 2,779
Not applicableEnded earlyNCT00428441
What this trial is testing

D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Università degli Studi dell'Insubria 73
Not applicableStudy completedNCT02836457
What this trial is testing

ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE

Who this might be right for
Venous Thromboembolism
Bristol-Myers Squibb 1,134
Load More Results